Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Drug safety advice
- Ciclosporin: must be prescribed and dispensed by brand name
- Finasteride: potential risk of male breast cancer
Yellow Card Scheme update
- Reporting of suspected adverse reactions to flu antivirals and flu vaccines
- How to complete a Yellow Card
End-of-year quiz
- Test your drug-safety knowledge
Stop press
- Etravirine: reports of severe hypersensitivity reactions
- Rituximab: progressive multifocal leukoencephalopathy in a patient without prior treatment for rheumatoid arthritis
- Warfarin: product information to be amended to give clearer, up-to-date advice
- Drug alert: recall of Gaviscon Advance Peppermint Flavour, Boots Heartburn Relief Peppermint Flavour, Peptac Peppermint Liquid, and Peptac Liquid Aniseed Flavour
Other information from the MHRA
- Patient Information Leaflet of the month: Arthrotec
Quiz answers
- How did you score?
Drug Safety Update: Volume 3 Issue 5, December 2009 
